Item 8.01 Other Events.

On July 20, 2022 the Company was notified that, effective July 21, 2022, our common stock would be downgraded from the OTC Pink Market to the OTC Expert Market of the OTC Markets Group because the Company was delinquent in making current information publicly available as required by SEC Rule 15c2-11. This occurred because the Company failed to file our Annual Report on Form 10-K for 2021 or our Quarterly Report on Form 10-Q for the first quarter ended March 31, 2022 within the applicable grace periods provided by the OTC Markets Group. Both of these reports could not be filed within the prescribed time period because of delays in the completion of management's evaluation of the Company's liquidity including the ability to meet day-to-day operating obligations.

Because of the restrictions imposed on securities quoted on the Expert Market, most investors will not be able to publicly sell their shares. Additionally, they will not have access to bid and ask prices or other information, including trading volume. As such, Expert Market shares are illiquid.

We are working on funding solutions for our working capital requirements to fund continued operations and we will proceed as quickly as possible with filing these reports with the SEC at which time we will apply for relisting on the OTCQB Market.

No assurance can be given that the Company will be successful in obtaining such financing and funding solutions sufficient to fund continued operations. In the absence of such financing the Company will be required to scale back or terminate operations and/or seek protection under applicable bankruptcy laws. An extended delay or cessation of the Company's continuing product development efforts will have a material adverse effect on the Company's financial condition and results of operations.

© Edgar Online, source Glimpses